Nova Eye Medical Limited (ASX:EYE) Directors Insider Transactions



The Directors and Chief Executives of Nova Eye Medical Limited (ASX:EYE) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Nova Eye Medical Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Nova Eye Medical Limited to the ASX stock exchange.

An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

Nova Eye Medical Limited Directors/Insider Transactions Activity

List of Insider trades activity from Nova Eye Medical Limited (EYE).

Date Director Director's Title Shares Value Note
01 Sep 2025 Spurling (Tom) Managing Director 78,273 - Purchase at price 0.00 per share.
04 Aug 2025 Spurling (Tom) Managing Director 300,000 - -
30 Jun 2025 Southard (Mike) Director (Executive) 41,666 - -
30 Jun 2025 Webb (Daniel) Director (Independent) 416,666 - -
26 Mar 2025 Previn (Victor Conrad) Executive Chairman 416,666 31,458 Other at price 0.08 per share.
26 Mar 2025 Spurling (Tom) Managing Director 166,666 12,583 Other at price 0.08 per share.
15 Mar 2024 Coupe (Rahmon Charles) Director (Independent) 149,022 20,520 Other at price 0.14 per share.
15 Mar 2024 Previn (Victor Conrad) Executive Chairman 1,233,948 169,914 Purchase at price 0.14 per share.
15 Mar 2024 Spurling (Tom) Managing Director 93,917 12,932 Purchase at price 0.14 per share.